Barth syndrome

Barth syndrome (BTHS), also known as 3-methylglutaconic aciduria type II, is an extremely rare X-linked multisystem disorder that is usually diagnosed in infancy.

Barth syndrome has an estimated prevalence of 1 in 300,000-400,000 live births.

It is characterized by:

Barth syndrome is caused by a mutated tafazzin (TAZ) gene (chromosome Xq28) which encodes an acyltransferase responsible for remodeling of cardiolipin in mitochondrial membranes, especially affecting cardiac myocytes, neutrophils and skeletal muscles. The inheritance pattern is X-linked recessive type 6.

Echocardiography may reveal left ventricular dilatation, hypertrophy of left ventricle and endocardial fibroelastosis. Cardiomyopathy can develop in utero 6.

It was first described by P G Barth et al. 2-4  in the year 1983.

Article information

rID: 15721
Section: Syndromes
Synonyms or Alternate Spellings:
  • Barth syndrome (BTHS)
  • Barth's syndrome
  • X-linked cardioskeletal myopathy
  • 3-methylglutaconic acid-uria type II
  • Endocardial fibroelastosis type 2
  • Cardioskeletal Myopathy, Barth Type
  • Cardioskeletal Myopathy With Neutropenia and Abnormal Mitochondria
  • X-Linked Cardioskeletal Myopathy and Neutropenia

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.